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Abstract
With the increased interest in new PET tracers, gene-targeted therapy, immunoPET,
and theranostics, other radioisotopes will be increasingly used in clinical PET scanners,
in addition to 18F. Some of the most interesting radioisotopes with prospective use
in the new fields are not pure short-range β+ emitters but can be associated with
gamma emissions in coincidence with the annihilation radiation (prompt gamma),
gamma-gamma cascades, intense Bremsstrahlung radiation, high-energy positrons
that may escape out of the patient skin, and high-energy gamma rays that result in
some e+/e− pair production. The high level of sophistication in data correction and
excellent quantitative accuracy that has been reached for 18F in recent years can be
questioned by these effects. In this work, we review the physics and the scientific
literature and evaluate the effect of these additional phenomena on the PET data
for each of a series of radioisotopes: 11C, 13N, 15O, 18F, 64Cu, 68Ga, 76Br, 82Rb, 86Y, 89Zr, 90Y,
and 124I. In particular, we discuss the present complications arising from the prompt
gammas, and we review the scientific literature on prompt gamma correction.
For some of the radioisotopes considered in this work, prompt gamma correction is
definitely needed to assure acceptable image quality, and several approaches have
been proposed in recent years. Bremsstrahlung photons and 176Lu background
were also evaluated.
Keywords: PET, Radioisotopes, Positron emitter, Prompt gamma, Non-conventional
PET isotopes
Introduction
With the rise of interest in new PET tracers, multiple-tracer PET imaging, gene-
targeted therapy, theranostics, and immunoPET [1–3], other radioisotopes are
expected to be increasingly used in clinical PET scanners, side by side with 18F. Some
short-lived radioisotopes have been extensively used in the past in the clinic or in re-
search: 15O and 11C for brain studies, 13N and 82Rb for cardiac studies, and 18F and
11C for several applications in oncology. 68Ga use is showing a dramatic growth be-
cause of the applicability in labeling both small compound and macromolecules and
because it is obtained from a relatively inexpensive 68Ge/68Ga generator system [4].
The use of monoclonal antibodies (mAb) as therapeutic target-specific agents has
generated an interest in PET labeling of mAb [5, 6]. In order to better match the
slower pharmacokinetics of the mAb, radioisotopes with a long half-life, such as 64Cu,
76Br, 86Y, 89Zr, and 124I, are more apt to follow the tracer and the radiopharmaceutical
for hours, days, or even weeks [7, 8].
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Moreover, the same radioisotopes are particularly suitable for the development of
molecular imaging in tandem with a therapeutic agent, pharmaceutical or radiothera-
peutic (also known as theranostics), for personalized treatment planning or real-time
therapy monitoring. For example, 86Y and 124I can be used as a surrogate of 90Y and
131I, β− emitters commonly adopted in radiotherapy, in order to accurately estimate the
most likely dose distribution before radiotherapy [9]. Recently, it has been shown that
90Y can simultaneously work as an imaging agent and a therapeutic agent [10].
Finally, PET imaging with multiple tracers could be instrumental to better under-
stand the molecular basis of a disease: multiple aspects of the disease can be character-
ized in the same study, and this would also allow for avoiding multiple scans, with cost
reduction and improved patient comfort [11]. PET radioisotopes could be identified by
different half-lives and also by their different decay mechanisms. In particular, a
compound labeled with a pure positron emitter, as 18F, can be used together with
another compound labeled with a radioisotope with a prompt gamma in coincidence
with the positron decay, as 124I or 86Y: using the differential count rates of dual and
triple coincidences can allow for differentiating and reconstructing the individual
radioisotope activities [11–13].
Some of the most interesting radioisotopes with prospective use in the new fields are
not pure short-range β+ emitters but can be associated with gamma emissions in coin-
cidence with the annihilation radiation (prompt gamma), gamma-gamma cascades,
intense Bremsstrahlung radiation, high-energy positrons that may escape out of the
patient skin, and high-energy gamma rays that result in some e+/e− pair production.
The high level of sophistication in data correction and excellent quantitative accuracy
that has been reached for 18F in recent years can be questioned by these effects. In this
work, we review the physics and the scientific literature and evaluate the effect of these
additional phenomena on the PET data for each of a series of radioisotopes: 11C, 13N,
15O, 18F, 64Cu, 68Ga, 76Br, 82Rb, 86Y, 89Zr, 90Y, and 124I. In addition, some experimental
results are analyzed, using data from work previously published, or data ad hoc
acquired for this article, in order to characterize the different phenomena.
The following effects will be discussed:
1) Prompt gamma emitted in coincidence with β+, within the energy window of the
PET scanner
2) High-energy prompt gammas that fall within the energy window of the scanner
after scatter in the patient
3) High-energy gammas generating e+/e− pair production in the tissue or in the
high Z detectors
4) High-energy positrons escaping the patient skin and annihilating in the
scanner tunnel
5) Bremsstrahlung radiation
6) Radiation and coincidences from 176Lu or other radioactive impurities in the
scintillator
Review
The decay schemes of the radioisotopes of interest have been studied and are available
through several reference web sites [14–16]. These are presented in simplified form in
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the Additional file 1 as a convenient summary for the reader. Radioisotope half-life,
branching ratio, and photon and positron energies, reported in this article in the “Pure
PET radioisotopes” and “PET radioisotopes with relevant contribution of prompt
gammas” sections, are from the same sources. The positron ranges in water, as a surro-
gate of human tissue, are from the National Institute of Standards and Technology web
site [14].
In this work, we focus on the aspects that could generate a viable PET signal. A few
parameters can drive the use and success of a PET radioisotope:
1) Short or long half-life: the former is typically convenient for high-statistics PET scan
of compounds that reach their target very quickly, like 15O in brain studies or
18F-FDG for oncology; the latter is used where the target is reached more
slowly, as in 89Zr-labeled or 64Cu-labeled antibody imaging.
2) Energy of the positron: the energy determines the range in the tissue. Better spatial
resolution can be reached with short-range positrons; 11C, 18F, 64Cu, and 89Zr are
typical short-range positron emitters, and 13N, 15O, 68Ga, 82Rb, and 124I are long-range
positron emitters (>1 mm).
3) Prompt gamma contamination: gammas emitted in decay cascades with the
positron emission produce spurious coincidences, which blur the PET image
and produce quantification errors, as in 76Br, 86Y, 82Rb, and 124I.
4) Emission of high-energy β− decay: some radioisotopes have an alternative high-
energy β− decay that could be used for radiotherapy, and the minority β+ decay
could be used for online monitoring or dosimetry of the radiotherapy, as in
64Cu or 90Y; others have a homologous radioisotope used for radiotherapy, and
the β+ emitter can be used for treatment planning of the β− emitter, as in 131I
(β− emitter) and 124I (β+ emitter).
For the sake of simplicity, we will organize the radioisotopes in terms of pure
positron emitter and prompt gamma positron emitters. A special class will be dedicated
to 90Y. A preliminary section is dedicated to a short review of the effect of positron
range on spatial resolution and methods to correct for this effect.
Effect of positron range on spatial resolution
Many of the PET radioisotopes suitable for immunoPET and theranostics emit positron
with long positron range. This implies a blurring of the source distribution and a
consequent loss of spatial resolution [17–19]. The loss of spatial resolution, compared
to short-range positron emitter such as 18F, has been measured in high-resolution PET
scanners for brain imaging and animal PET [20, 21]. For the present generation of
commercial whole-body PET scanners, with spatial resolution of about 4 mm, the
blurring due to positron range is barely measurable [22]. Nevertheless, in the future,
even whole-body PET, with improved spatial resolution, might require a mechanism to
recover the loss of resolution associated with long positron range.
An accurate characterization of the point spread function (PSF) allows for compensa-
tion of the loss in contrast recovery using calculated spill-over and partial volume
corrections [23]. Methods to correct for positron range have been presented, as
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deblurring techniques [24] or incorporating positron range in the reconstruction itself
[25]. Other researchers used the Monte Carlo simulation to estimate the distance
between the source position and the detection line of response in the PET scanner and
then incorporated this information in the reconstruction [19, 26]. The increasing use of
these long-positron-range radioisotopes will make methods for resolution recovery
even more necessary.
In addition, the long positron range of some of these radioisotopes can not
only blur the primary radioisotope distribution but can also generate image arti-
facts. The positrons can exit the target organs and travel in air annihilating in a
location where there is no tracer uptake, generating “ghost” uptake. This
phenomenon has been observed in the trachea and in the larynx when 124I and
68Ga are used [27, 28], but it could also be present in low-density organs such as
the lungs, especially in PET/MR systems where the positrons may follow the dir-
ection of the magnetic field.
Pure PET radioisotopes
The most commonly used PET radioisotopes, such as 11C, 13N, 15O, and 18F, have short
half-lives and high branching ratios for β+ decay. 89Zr has a long half-life, low branching
ratio for β+ decay, and moderate-range positron emission, feeding an excited state with
such a long half-life that the associated gamma ray from this excited level is not in coinci-
dence with the PET signal. 64Cu has a long half-life, low branching ratio for β+ decay,
short-range positron emission, and an additional decay branch via β− emission. The main
properties of these radioisotopes are summarized in Table 1.
11C decays into 11B with a half-life t1/2 = 20.4 min. The decay is 99.8 % by β
+
and 0.2 % by electron capture (EC, no radiation emitted). The emitted positron
has 0.960-MeV maximum energy (Emax) and 0.386-MeV mean energy (Emean),
which corresponds to a 4.2-mm maximum range in water (Rmax) and a 1.2-mm
mean range in water (Rmean).
13N decays into 13C with a half-life t1/2 = 10.0 min. The decay is 99.8 % by β
+ and
0.2 % by EC (no radiation emitted). The emitted positron has Emax = 1.199 MeV and
Emean = 0.492 MeV, which corresponds to a Rmax = 5.5 mm and a Rmean = 1.8 mm.
15O decays into 15N with a half-life t1/2 = 2.0 min. The decay is 99.9 % by β
+ and
0.1 % by EC (no radiation emitted). The emitted positron has Emax = 1.732 MeV and
Emean = 0.735 MeV, which corresponds to a Rmax = 8.4 mm and a Rmean = 3.0 mm.
Table 1 Properties of pure positron emission radioisotopes. Data from the National Institute of
Standards and Technology [14], Laboratoire National Henri Becquerel [15], and Brookhaven
National Laboratory [16]. Range of positrons is in water [14]
Isotope Half-life Branching (β+) in % Emax (MeV) Emean (MeV) Rmax (mm) Rmean (mm)
11C 20.4 min 99.8 0.960 0.386 4.2 1.2
13N 10.0 min 99.8 1.199 0.492 5.5 1.8
15O 2 min 99.9 1.732 0.735 8.4 3.0
18F 110 min 96.9 0.634 0.250 2.4 0.6
64Cu 12.7 h 17.5 0.653 0.278 2.5 0.7
89Zr 78.4 h 22.7 0.902 0.396 3.8 1.3
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18F decays into 18O with a half-life t1/2 = 110 min. The decay is 96.9 % by β
+ and
3.1 % by EC (no radiation emitted). The emitted positron has Emax = 0.634 MeV and
Emean = 0.250 MeV, which corresponds to a Rmax = 2.4 mm and a Rmean = 0.6 mm.
64Cu decays, with a half-life t1/2 = 12.7 h, either β
− into 64Zn (38.5 %, with
Emax = 0.579 MeV) or into
64Ni (61.5 %) via a combination of EC and β+. The
EC has a branching ratio of 43.5 %, while the β+ decay is 17.5 %. The emitted
positron has Emax = 0.653 MeV and Emean = 0.278 MeV, which corresponds to a
Rmax = 2.5 mm and a Rmean = 0.7 mm.
89Zr decays into a metastable-state 89mY, with a half-life t1/2 = 78.4 h. The decay is
22.7 % by β+ and 76.2 % by EC. The rest (1.1 %) of 89Zr decays by EC into several ex-
cited levels of 89Y, followed by emission of γs into the same metastable-level 89mY. The
emitted positron has Emax = 0.902 MeV and Emean = 0.396 MeV, which corresponds to a
Rmax = 3.8 mm and a Rmean = 1.3 mm. The metastable-level
89mY decays (t1/2 = 16 s) to
a ground-state 89Y by emission of a γ (0.909 MeV). Because of the long half-life of this
metastable-level 89mY, the γ is in cascade with β+ but cannot be considered in coinci-
dence and it does not behave as a prompt gamma.
PET radioisotopes with relevant contribution of prompt gammas
The isotopes 68Ga, 76Br, 82Rb, 86Y, and 124I have complex decay schemes with a variety
of gammas in coincidences. Some of them emit prompt gammas that directly fall into
the energy window accepted by the PET scanner; others emit high-energy prompt
gammas that have some probability of generating spurious coincidences after scattering
in the patient or via e+/e− pair production in the detector or the patient. The main
properties of these radioisotopes are summarized in Table 2.
68Ga decays into 68Zn, with a half-life t1/2 = 67.8 min. The decay is 88.9 % by β
+ and
11.1 % by EC. The main β1
+ decay (87.7 %) is to the ground level of 68Zn (Emax = 1.899 MeV,
Emean = 0.836 MeV, Rmax = 9.2 mm, Rmean = 3.5 mm), and it is a pure positron emission
branch. A small fraction decays β2
+ (1.2 %) into an excited level of 68Zn, which
promptly (t1/2 = 1.6 ps) decays into the ground level with a γ1 (1.077 MeV). This
can constitute a small prompt gamma contamination in the PET data, if the 1.077-MeV
γ1 has a scatter interaction in the patient, and generates a detectable lower energy γ in
coincidence with the positron annihilation pair. The principal EC branches are to
the ground level (8.9 %) or to the first excited level (1.8 %). The rest of the EC
(0.4 %) decays are into short-life excited levels emitting γs of various energies
(0.227–2.821 MeV), with negligible probability to be detected in coincidence.
Table 2 Properties of prompt gamma positron emission radioisotopes. Only the positrons and
prompt gammas with the two highest branching ratios are listed. Data from the National Institute
of Standards and Technology [14], Laboratoire National Henri Becquerel [15], and Brookhaven
National Laboratory [16]
Isotope Half-life Branching (β+) in % β+ Emax (MeV) Branching (γ) in % γ E (PG) (MeV)
68Ga 67.8 min 87.7, 1.2 1.899, 0.821 3.2 1.077
76Br 16.2 h 25.8, 6.3 3.382, 0.871 74.0, 15.9 0.559, 0.657
82Rb 1.3 min 81.8, 13.1 3.378, 2.601 15.1 0.777
86Y 14.7 h 11.9, 5.6 1.221, 1.545 82.5, 32.6 1.077, 0.627
124I 100.2 h 11.7, 10.7 1.535, 2.138 62.9, 11.2 0.602, 1.691
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76Br decays into 76Se, with a half-life t1/2 = 16.2 h. The decay is 54.8 % by β
+ with dif-
ferent energies and 45.2 % by EC. The only pure positron emitter decay β3
+ decays to
the ground level of 76Se with a branching ratio of only 6.0 %. The other major β+ decay




+ (25.8, 6.3, and 5.2 %, respectively) and a large number of other β+ decays
that add up to 11.5 %. Most β+s are in cascade with a prompt gamma γ1, with energy
(0.559 MeV) very close to the typical PET energy window. In summary, about 90 % of
76Br positrons are associated with one or more prompt gammas. A large fraction of
prompt gammas has energy within the PET energy window; a smaller fraction of the
high-energy gammas could scatter in the patient and produce photons also within the
PET energy window; and others can directly generate e+/e− pairs. The energy of the β+
is typically high, with a long range and resulting in poor spatial resolution.
82Rb decays into 82Kr, with a half-life t1/2 = 1.3 min. The decay is β
+ with two main
energies. The pure positron decay β1
+ is to the ground level of 82Kr, with a branching ra-
tio of 81.8 % (Emax = 3.378 MeV, Emean = 1.535 MeV, Rmax = 17.0 mm, Rmean = 7.1 mm).
The second most frequent positron decay β2
+ is to an excited level of 82Kr, with a
branching ratio of 13.1 % (Emax = 2.601 MeV, Emean = 1.168 MeV, Rmax = 13.0 mm,
Rmean = 5.0 mm). As a consequence, a prompt gamma γ1, with energy 0.777 MeV, is
emitted in cascade, generating prompt gamma coincidences, mainly after scatter in the
patient body. Both β1
+ and β2
+ have high energy and consequently long ranges.
86Y decays into 86Sr, with a half-life t1/2 = 14.7 h. The decay is 31.9 % by β
+ with
different energies and 68.1 % by EC. All β+ decay modes populate excited levels of 86Sr,
with emission of cascades of prompt gammas. The main β+ decay modes are β1
+
(11.9 %, Emax = 1.221 MeV, Emean = 0.535 MeV, Rmax = 5.6 mm, Rmean = 1.9 mm), in
cascade with γ5 (1.920 MeV) and γ1 (1.077 MeV); β2
+ (5.6 %, Emax = 1.545 MeV,
Emean = 0.681 MeV, Rmax = 7.1 mm, Rmean = 2.8 mm), in cascade with γ7 (0.443 MeV),
γ3 (1.153 MeV), and γ1 (1.077 MeV); and β3
+ (3.6 %, Emax = 1.988 MeV, Emean = 0.883 MeV,
Rmax = 9.7 mm, Rmean = 3.7 mm), in cascade with γ3 (1.153 MeV) and γ1 (1.077 MeV).
Even non-β+ decays generate cascades of gammas in coincidence. All gamma cascades
can generate spurious coincidences: some prompt gammas have energy within the PET
energy window. Part of the high-energy gammas could scatter in the patient and
produce photons also within the PET energy window, and others can directly
generate e+/e− pairs. The energy of the β+ is typically high, with a long range and
with degraded spatial resolution.
124I decays into 124Te, with a half-life t1/2 = 100.2 h. The decay is 77.3 % by EC and
22.7 % by β+ with two main modes: a pure positron decay to the ground level of 124Te,
β2
+ (10.7 %, Emax = 2.138 MeV, Emean = 0.975 MeV, Rmax = 10.0 mm, Rmean = 4.4 mm),
and a β1
+ mode (11.7 %, Emax = 1.535 MeV, Emean = 0.687 MeV, Rmax = 7.1 mm,
Rmean = 2.8 mm), which decays into an exited state of
124Te, with a prompt gamma
emission γ1 (0.602 MeV). There is an additional β3
+ (0.3 %, Emax = 0.812 MeV,
Emean = 0.367 MeV, Rmax = 3.4 mm, Rmean = 1.1 mm), with a prompt gamma emission
γ3 (0.723 MeV), also in cascade with emission γ1 (0.602 MeV). Moreover, a large part of
the excited level is populated by EC decays via gamma cascades into the first excited level
of 124Te that decays into the ground level with the same γ1 (602 MeV), and they can
produce coincidences between γ1 and photons in the cascade. Some gammas have energy
within the PET energy window. A fraction of the high-energy gammas could undergo
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Compton scatter in the tissue, and the scattered photons might enter the PET energy
window. Other high-energy gammas can directly generate e+/e− pairs. The energies of the
β+ are high, associated with a long range and poor spatial resolution.
90Y, a non-β+ decay PET radioisotope
90Y is mainly a β− emitter used for radiotherapy and associated with very high
Bremsstrahlung radiation but has a very small branching ratio that produces e+/e−
pairs, a weak but viable PET signal [10].
90Y decays (t1/2 = 64.1 h) 99.99 % into the ground-level
90Zr by β1
− (2.280 MeV) and
0.0115 % into an excited level of 90Zr by β2
− (0.519 MeV). The high-energy β1
− is used
for radiotherapy, and the fast electrons of β1
− emit strong Bremsstrahlung radiation.
The excited level associated with β2
− decays into a ground state of 90Zr by internal con-
version (0.0083 %) or creation of an e+/e- pair (0.0032 %) [29]. This small branching ra-
tio in the e+/e- pair annihilates and can be observed as a PET signal. The e+/e- pair can
have a maximum total kinetic energy of 0.739 MeV; therefore, it has a short range.
Prompt gamma characterization
PET data reconstruction is based on a two-step process: estimating the corrections to
the data and image reconstruction itself. The data corrections are normalization (indi-
vidual detector sensitivity, sensitivity profile differences due to radial position of the
source, and other factors relative to the scanner geometry), attenuation correction (due
to the interaction of emitted photons with the patient tissue), random correction (acci-
dental coincidence of uncorrelated photons at a high count rate), and scatter correction
(photons having a Compton interaction in the patient and therefore changing energy
and direction). Typically, all corrections assume that only two back-to-back 511-keV
photons from positron annihilation are involved: individual detector sensitivity is
measured with 511-keV photons, attenuation correction is measured with CT X-rays
but is converted into a 511-keV attenuation coefficient, and scatter is simulated or esti-
mated based on single (or multiple) scatter simulations or models of interaction of
511-keV photons. Randoms are usually estimated using a delayed window or from sin-
gle models, measuring single count rates in detector. Because of this, the random
estimate does not include any assumption about the energy or the direction of the
detected photons, and a random estimate method can work with any radioisotope.
Most clinical applications of PET require 18F-FDG PET imaging. Tracers based on
18F are pure β+ emitters, and only 511 keV is emitted. Moreover, 18F’s positrons have a
short range (<1 mm), and the position of the radioisotope can be approximated with
the position of the positron annihilation. As we discussed in the previous section, also
11C, 13N, and 15O are pure positron emitters. Because of the longer range of 13N and
15O, those radioisotopes might result in slightly blurred images or require positron
range deblurring. 64Cu and 89Zr can be considered pure β+ emitters, even though they
have a much lower branching ratio: 64Cu decays β+ to the ground level of 64Ni, and
89Zr decays β+ to a metastable level of Yttrium 89mY, but the long half-life of the meta-
stable level (15.8 s) makes the associated gamma not in coincidence.
If the decay scheme is more complex and involves additional radiation in coinci-
dence, then the approximations for pure β+ emitters do not hold well, and the data
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correction is more difficult, as in the case of 68Ga, 76Br, 82Rb, 86Y, and 124I. Spurious
coincidences can be produced by prompt photons or high-energy photons generated
during the decay of the injected radioisotope (Fig. 1). A prompt gamma can be detected
because it has energy within or close to the PET energy window (Fig. 1a) or after it
undergoes Compton scatter that reduces its energy (Fig. 1b). Moreover, high-energy
gammas—in cascade with a β+ or β− decay or produced by another decay mechan-
ism—can reach the detectors and generate e+/e− pairs (Fig. 1c). In this case, their
energy must be over the threshold of 1.022 MeV, and the pair production probability
increases with the photon energy. Also, in some decay modes, high-energy levels are
populated via EC, and they decay to the ground level in cascade of two or more
gammas. These cascades add to the background of spurious coincidences.
Finally, radioisotopes with a prompt gamma can generate not only coincidences
between two photons but also triple coincidences, between two annihilation gammas
and a prompt gamma. The fraction of triple coincidences has been estimated to be
about 25 % for 124I and greater than 50 % for 86Y [30]. The different ratios of double
and triple coincidences in pure beta emitter and non-pure beta emitter have been
exploited as a method to differentiate radioisotopes in multiple-tracer imaging [12, 13].
The contribution of the prompt gamma coincidences has a different spatial distribu-
tion when compared to the pure annihilation coincidences. This can be observed by
looking at the radial profiles of sinograms obtained using the same phantom but with
different radioisotopes. The data, reprocessed for this article, were acquired during an
experiment aimed to characterize PET scanner performance, and details are given in
[22]. A NEMA image quality phantom was scanned in the same position several times
and filled with water solutions of several radioisotopes used for PET imaging: 11C, 18F,
64Cu, 68Ga, 89Zr, 90Y, and 124I. The phantom was scanned on a Siemens mCT PET/CT
scanner, and 200 million net true counts, defined as prompt coincidences after delayed
subtraction, were acquired for each experiment (only 10 million for 90Y). In Fig. 2, the
radial profile is plotted for all the radioisotopes, after normalization to maximum value.
One can observe that 18F, 11C, 64Cu, and 89Zr (pure β+ emitters) have very similar radial
profiles; in fact, they fully overlap in the noisy regions of the plot. Also, the tails of the
sinograms quickly decrease. 68Ga exhibits slightly higher tails, compared to the pure β+
Fig. 1 Three mechanisms associated with prompt gamma spurious coincidences: a 124I has a prompt
gamma of energy within or close to the PET energy window (603 keV); b 68Ga has a prompt gamma of
energy that can enter the PET energy window if it undergoes Compton scatter (1077 keV); and c 76Br has
several high-energy gammas that can reach the detectors and generate e+/e− pairs
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emitters, which is evidence of a minor presence of prompt gammas. As expected, 124I
has a large fraction of the coincidences that appear to have originated outside the
phantom, a substantial contribution from prompt gamma coincidences. 90Y has
intermediate behavior, with small but visible tails increasing towards the edges of
the scanner.
In fact, 68Ga has only 1.2 % of β+ to an excited level, associated with a 1.077-MeV γ,
compared to 87.7 % of β+ to the ground level. And the prompt gamma contribution to
coincidences is even lower because the γ has to scatter and reduce its energy to be
detected. Nevertheless, it has been observed that if the 68Ga activity is concentrated in
a specific organ, and the scatter is evaluated away from the concentrated activity, this
small background of the prompt gamma can create artifacts and generate scatter
overestimate. In these occurrences, it has been recommended to use some prompt
gamma correction even for 68Ga [31].
82Rb, used for cardiac studies, has a higher prevalence of the prompt gamma, 13.1 %
of β+ to an excited level, associated with a 0.777-MeV γ, compared to 81.8 % of β+ to
the ground level. The detection probability of the prompt gamma is reduced by the fact
that only a small fraction of the 0.777-MeV γs falls into the energy window (typically,
the upper threshold is between 550 and 650 keV) and another fraction enters the
window only after scattering in the tissue. In any case, a prompt gamma correction is
absolutely necessary for 82Rb.
For both 82Rb and 68Ga, a uniform radial offset or a first-order polynomial well
describe the prompt gamma, probably because the scattered detected gammas have
quite a flat spatial distribution.
The contribution of the prompt gamma becomes prevalent in 124I, where 10.7 % are
β+ decays to the ground level and 11.7 % are β+ decays to the excited level associated
with a 0.603-MeV γ, fully within the PET energy window. Moreover, some of the
remaining 77.3 % of the EC decays generated cascades of γs terminating in the same
0.603-MeV excited level, with possible additional spurious coincidences. In fact, we
could roughly estimate the ratio of the prompt gamma over total coincidences in a
sinogram. “True” coincidences (two 511-keV photons) are about 10.7 % + 1/3 11.7 %
Fig. 2 Radial net true sinogram profiles (all angles added) of a NEMA image quality phantom, filled with
water solutions of several radioisotopes used for PET imaging: 68Ga (thick black line), 90Y (thin red line), 124I
(thick red line), and 11C, 18F, 64Cu, and 89Zr (all in black dotted lines). The phantom was scanned on a Siemens
mCT PET/CT scanner. The profile is shown after normalization to maximum, a in linear scale and b log scale
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(considering a triple event with two 511-keV photons and one 603-keV photon).
“Prompt gamma” coincidences (one 511-keV photon and one 603-keV photon) are
about 2/3 11.7 %. This results in a ratio of the prompt gamma over total of about 0.35,
a relevant fraction of the total coincidences. Figure 3 shows a second-order polynomial
fit of the background in the image quality phantom sinogram; with this fit, we
measured a 0.33 ratio of the prompt gamma over total coincidences. A second-order
polynomial seems a better fit for 124I, due to the concavity of the background. One pos-
sible explanation for this shape is the fact that the 603-keV photons are directly de-
tected into the energy window and the spatial distribution is dictated by the simple
attenuation of the photons in the tissue [32].
Finally, 76Br and 86Y are dominated by decay schemes with prompt gammas. For 76Br,
the largely dominant main β+ decay (25.8 %) is associated with a 0.559-MeV γ; in
addition, other decay modes are characterized by γ cascades. In the 86Y, all the domin-
ant β+ decays (11.9, 5.6, and 3.6 %) are associated with a 1.077-MeV γ; in addition,
other decay modes terminate into the same 1.077-MeV level. Prompt gamma correc-
tion is absolutely necessary, since spurious coincidences are the majority of the coinci-
dences for these radioisotopes.
Prompt gamma correction
Standard scatter correction and random correction alone are not sufficient to obtain
quantitative images in the presence of abundant spurious coincidences from prompt
gammas. In the absence of proper correction, this results in high artifact background
levels and consequent loss of contrast, or overestimation of the conventional scatter,
with over subtraction in the central part of the body. In order to mitigate the effect of
the prompt gamma, it has been shown that a narrower energy window can effectively
reduce the prompt gamma contamination in the data [33]. This alone does not elimin-
ate the problem, particularly in situations where the prompt gammas have energy very
close to the conventional PET energy (511 keV) or the prompt gamma coincidences
are the majority component. Moreover, it does reduce the sensitivity of the PET
Fig. 3 Radial net true sinogram profiles (all angles added) of a NEMA image quality phantom, filled with
water solutions of 124I. A second-order polynomial is used to fit the background: the 124I profile (black line),
the second-order polynomial fit (red line), and the tail region used for the fit (thick red dotted line) are
shown. The phantom was scanned on a Siemens mCT PET/CT scanner
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scanner to true coincidences. A new correction is needed, the prompt gamma correc-
tion (PGC). In the past years, several methods have been proposed to estimate and
subtract the prompt gamma component.
The first group of methods consists of estimating the prompt gamma background
fitting the radial tails of the sinogram with a constant offset and first- or second-order
polynomials. At the radial extremities of the sinogram, no source of activity is present,
the single or multiple scatter of 511 keV from positron annihilation is negligible. The
offset due to prompt gammas can be evaluated and subtracted. Subtracting a simple
uniform background has been shown to be effective even with 86Y and 124I, which have
abundant prompt gamma fraction [34–36]. A linear approximation of the background
has been used successfully for 76Br and proposed in general for all prompt gamma
radioisotopes [37–39]. In order to better match the slightly concave shape of the
background observed in 86Y and 124I [34], a second-order polynomial fit to the tails has
been proposed (and tested on 86Y) [40].
A second approach is based on the observation that, for 82Rb, the prompt gamma
background has a similar radial distribution as the randoms [41]. The authors proposed
a method that uses the scaled random estimate, added to the single scatter conven-
tional estimate, to match the tails of the prompt sinogram. The random scaling factor,
obtained by fitting the tails, includes the prompt gamma contribution. This approach
to prompt gamma correction was also used on 124I data, where the 124I image quality
after PGC was comparable to that shown in a similar experiment with 18F [42].
A third approach is based on a convolution of the estimate of the original activity
with some kernel based on models that include prompt gamma generation. One option
uses a spatially variant, attenuation-dependent kernel that has been analytically deter-
mined and is based upon a simplified model of the cascade-coincidence attenuation
and detection process [43]. The model is based on the measured attenuation map of
the patient. In this method, the emission sinogram is preliminarily corrected with the
standard corrections, then convolved with the kernel, and the tails of the convolved
sinogram and the measured sinogram are fitted to obtain a scaling factor for the convo-
lution kernel. Then, the scaled kernel can be used for the final estimate of the prompt
gamma correction. This method has been tested with 76Br and 86Y data. Another group
proposed a correction method for 86Y, based on the convolution of the estimate of the
original activity with a 86Y point spread function kernel [44]. The resulting prompt
gamma estimate is then normalized to counts outside the patient body, in order to
obtain a more accurate correction. The method can be iterated. The 86Y point spread
function kernel was measured once with an elliptical phantom that simulates the
abdomen. Even with its limitation (the point spread function is based on a phantom),
the results are encouraging.
A fourth approach is based on a simple attenuation model (SAM) for prompt
gammas [32], analog to the single scatter model for single scatter simulation (SSS) [45].
This method assumes that the principal effect driving the spatial distribution of the
prompt gamma coincidences in 124I is the simple attenuation of the 0.603 MeV in the
patient body. The attenuation probability, for each source position and each detector, is
computed geometrically, based on the expected travel path in the patient. As for the
SSS, the original emission sinogram and the measured attenuation map of the patient
are used to estimate a first approximation of the activity distribution. At each iteration,
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the attenuation of the prompt gammas is estimated via the new SAM method and the
scatter of the annihilation photons via the conventional SSS. This method has shown
excellent matching of the radial shape for 124I [32].
Finally, a possible but time-consuming solution is a full Monte Carlo simulation of
the emission and interaction of all radiation in the prompt gamma radioisotopes. Fast-
simulation packages for PET like SimSET have been used [46]. GATE Monte Carlo
simulation was successful for a complete simulation of non-pure radioisotopes, and it
was used as a support for estimating suitable functions modeling the tails of the sino-
grams. In particular, a two-component correction was proposed with the aid of GATE
simulations, a uniform background and a Gaussian function [47, 48].
Additional sources of spurious coincidences: positron range, Bremsstrahlung X-rays, LSO
background
Three additional phenomena can contribute to data contamination: high-energy posi-
trons interacting with the scanner tunnel, background radiation in detectors such as
lutetium orthosilicate (LSO) and lutetium yttrium orthosilicate (LYSO), and Brems-
strahlung X-rays emitted by slowing down of high-energy β− or β+, which can create e
+/e− pairs in the detectors (Fig. 4). In this section, we will briefly discuss these effects.
High-energy positrons, associated with ranges larger than a few millimeters, can
escape the patient skin. The positrons can travel in air and reach the PET scanner
internal tunnel, where they annihilate and produce two 511-keV gammas in coinci-
dence, completely uncorrelated with the distribution of the radioisotope in the patient
(Fig. 4a). This effect might be present in β+ emitters with a high branching ratio for
high-energy positrons: 68Ga (87.7 % of β+ with Rmax = 9.2 mm and Rmean = 3.5 mm),
76Br (25.8 % of β+ with Rmax = 17.4 mm and Rmean = 7.1 mm),
82Rb (81.8 % of β+ with
Rmax = 17.0 mm and Rmean = 7.1 mm),
86Y (with most of β+ with Rmax between 5 and
15 mm), and 124I (11.7 % of β+ with Rmax = 7.1 mm and Rmean = 2.8 mm and 10.7 % of
β+ with Rmax = 10.0 mm and Rmean = 4.4 mm).
Fig. 4 Additional mechanisms associated with spurious coincidences: a high-energy positrons, escaping the
patient skin, can travel in air and reach the PET scanner internal tunnel, where they annihilate and produce
two 511-keV gammas in coincidence; b in LSO- or LYSO-based PET scanners, a small background of 176Lu
radiation can generate coincidences between β− in a detector and two photons (307 keV + 202 keV) in
another; and c high-energy Bremsstrahlung X-rays can be emitted by slowing down of high-energy β− or
β+ and create e+/e− pairs in the detectors
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We have performed a simple experiment to visualize the β+ traveling in air, when the
energy is high enough to escape the patient or the phantom. A 5.4-cm-diameter cylin-
drical 68Ge phantom was placed at the center of a Siemens mCT scanner, with and
without a copper shield (0.64 mm). 68Ge disintegrates 100 % (half-life 270 days) by EC
to a 68Ga ground state, and it is effectively a 68Ga source. The source external wall
was 3 mm of plastic that has the density of water, which is not enough to stop β+ with
Rmax = 9.2 mm and Rmean = 3.5 mm. In Fig. 5a, a transaxial plane of the iterative
reconstruction image of the activity distribution in the phantom without copper
shield is shown. In Fig. 5b, the image of the phantom wrapped in copper foil is shown.
One can observe the presence of the copper shield, stopping the positrons that other-
wise would travel in air and reach the internal tunnel of the PET scanner. In the
absence of the shielding, the spatial distribution of coincidence events is affected by
the high-range positrons. In fact, similar effects have been observed in patient and
phantom data, if 124I and 68Ga are used [27, 28].
The 68Ge source was held in place in the center of the field of view by a polymer
foam holder covering the bottom part of the tunnel. The foam is unable to stop 511-
keV photons but can reduce the flux of positrons reaching the lower part of the tunnel
(Fig. 6a). At angle zero (top view), the radial distribution is fully symmetrical. An asym-
metry can be observed at a 90° view (side view) (Fig. 6b): the right-side tail shows a
drop of counts that is due to the suppression of the β+ flux reaching the tunnel. In fact,
while this effect can be observed in phantoms, in patients, it might be very negligible. If
the radiotracer is highly specific, the β+ emission is likely to be concentrated in the
internal organs of interest, and the high attenuation will prevent the β+ from exiting
the body. If the tracer is less specific and abundantly reaches the patient skin, this effect
can appear.
In addition, sources of radioactivity completely independent of the patient can gener-
ate a background radiation: for example, in LSO- or LYSO-based PET scanners, a small
background of 176Lu radiation can be seen when the PET signal in the patient is
extremely low, as in 90Y imaging. LSO contains 2.6 % of 176Lu, a radioactive isotope
that decays β− into 176Hf with a cascade of γ photons in coincidence, with 307-,
202-, and 88-keV energies. A coincidence of a β− in a detector and two photons
Fig. 5 Transaxial planes of the reconstructed images of 68Ge/68Ga cylindrical source in the scanner, a
without and b with a copper shield. The positrons escaping the phantom annihilate in the copper, which
becomes a source of 511 gamma pairs, and are visible in the image as a shell surrounding the phantom
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(307 keV + 202 keV) in another is unlikely but possible (Fig. 4b). The 176Lu β− in a
detector generates about 5000 single counts per second per block or a total random
counts of about 1100 s−1 in a four-ring Biograph mCT [49, 50]. This is a small but
not negligible background for some applications at a very low count rate, such as
with 90Y imaging. On the other hand, it has been demonstrated that randoms can
be properly measured and corrected using standard random correction, even for 90Y
imaging [50]. From the point of view of net true coincidence rate, after random sub-
traction, about 1 to 5 total count/s have been measured in the same four-ring LSO-
based mCT when no source was present [49, 50].
The small contribution of LSO background in extremely low count scans can be
appreciated in Fig. 7, where the sinogram profiles of true counts per second are shown
for a 90Y image quality phantom. The data were acquired during an investigation aimed
to characterize PET imaging of 90Y [50] and were re-analyzed for the present article.
The upper black curve is a 30-min scan at 3.785 GBq, the lower black curve is a 30-
min scan at 0.613 GBq, the red line represents a background measurement with no
source, and the broken red line represents a second-order polynomial fit to the back-
ground. The background is 6.5 total net true/s. One can observe that at extremely low
counts, the tails of the 90Y match the background measurement, while some residuals
can be seen at the higher count rate, possibly due to residual scatter or pair production
from high-energy Bremsstrahlung photons.
In the presence of very high activity, high-energy β− or β+ can produce Bremsstrahlung
radiation (Fig. 4c). Generally, a few thousands of MBq of 90Y are injected in the patients,
and the 99.98 % of high-energy β−s from the decay produce a very high flux of
Bremsstrahlung X-rays, which have a broad spectrum with endpoint 2.279 MeV. They
can reach the detectors and produce e+/e− pairs and therefore annihilation photons. Some
authors propose this as an explanation for the low background tails as seen in Fig. 7 [51].
All the possible phenomena (LSO background, Bremsstrahlung X-rays) add up to a
small net true contribution that still need to be properly considered for 90Y imaging,
Fig. 6 a Drawing of a 68Ge/68Ga phantom on a foam support inside a PET scanner tunnel. b Net true
sinogram radial profile in the top-view projection, or at 0° (black line), and in the side-view projection,
or 90° (red line)
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given the extremely low 90Y branching ratio of the e+/e− pair production [52, 53].
Nevertheless, even with a background of singles, randoms, and net trues, LSO and
LYSO scanners have been proven to function better than BGO-based scanners because
of the time-of-flight capability associated with fast LSO/LYSO scintillators [53]. In
general, the extremely small background of net true coincidences is neglected, and no
additional correction, apart from standard scatter and random corrections, is
performed for 90Y imaging in the commercial PET scanners.
Conclusions
With the foreseeable growth of the use of PET beyond conventional 18F-FDG oncology,
PET scanner performance needs to be characterized with a wider range of radioisotopes
that are not all pure β+ emitters. In this article, we reviewed the physics of several most
used or most promising radioisotopes, with focus on the features that can generate
artifacts or challenges to the image reconstruction. In particular, we discussed the
present complications arising from the so-called prompt gammas, and we reviewed the
limited scientific literature on prompt gamma correction. The effect of high positron
range, Bremsstrahlung photons, and 176Lu background were also evaluated.
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